Scientists imagine that combining navitoclax with ruxolitinib may help individuals with myelofibrosis. In this demo half the folks have navitoclax and ruxolitinib. Another half have ruxolitinib and a dummy drug (placebo ). This trial was sponsored by Abbott Laboratories and Genentech. M06-814 was the main in human protocol submitted by https://nicholask666ykw9.wikipowell.com/user